Last reviewed · How we verify
NCT04386525: OmegaStroke
Omega 3 and Ischemic Stroke; Fish Oil as an Option
Phase 4 trial testing Omega-3 fish oil in Ischemic Stroke in 60 participants. Status unknown.
30 December 2021
Quick facts
| Lead sponsor | King Fahad Medical City |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 September 2020 |
| Primary completion | 30 December 2021 |
| Estimated completion | 1 February 2022 |
Drugs / interventions tested
- Omega-3 fish oil
Conditions studied
- Ischemic Stroke — all drugs for Ischemic Stroke →
- Neurological Injury — all drugs for Neurological Injury →
- Stroke, Acute — all drugs for Stroke, Acute →
- Inflammatory Response — all drugs for Inflammatory Response →
Sponsor
King Fahad Medical City — full company profile →
Who can join
Adults 18 to 110, any sex, with Ischemic Stroke or Neurological Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this trial, The investigators are going to investigate the improvement of neurological functions and infarced area of the brain in ischemic stroke patients after ingestion of omega 3 products that have high concentrations of DHA and EPA in comparison to control group. The study will assess the improvement by computerized calculation of the size of the infarcted area before and after the intervention and neurological assessment tools. The researchers will follow the scientific and ethical regulations prevent any harmful effect on recruited subjects.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Late Breaking Abstracts.
· 2021 · cited 10× · PMID 35252583 · DOI 10.1177/23969873211044666 -
Nutritional therapy for reducing disability and improving activities of daily living in people after stroke.
Sakai K, Niimi M, Momosaki R, Hoshino E, et al · · 2024 · cited 4× · PMID 39145517 · DOI 10.1002/14651858.cd014852.pub2 -
Marine-derived n-3 fatty acids therapy for stroke.
Alvarez Campano CG, Macleod MJ, Aucott L, Thies F. · · 2022 · cited 4× · PMID 35766825 · DOI 10.1002/14651858.cd012815.pub3 -
The consumption of dietary supplements in Saudi Arabia during the COVID-19 pandemic: A cross-sectional study.
Azhar W, Al-Otaibi K, Abusudah WF, Azzeh F, et al · · 2023 · cited 2× · PMID 37746046 · DOI 10.1016/j.jsps.2023.101779
Verify or expand the search:
- PubMed search for NCT04386525
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Omega-3 fish oil
Trials testing the same drug.
- NCT02676466 — The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study · Phase 2 · completed
- NCT03448185 — Improving Metabolic Health in Patients With Diastolic Dysfunction · NA · completed
Other recruiting trials for Ischemic Stroke
Currently open trials in the same condition.
- NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
- NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
- NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
- NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
- NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting
Other King Fahad Medical City trials
Trials by the same sponsor.
- NCT06416202 — Closed Loop Pumps vs. Traditional Open Loop Pumps in Managing Blood Glucose Levels in T1DM Patients Fasting in Ramadan. · NA · active not recruiting
- NCT06945744 — Carbohydrate Counting and Bolus Calculator Mobile Application Improves Time in Range in Adults With Type 1 Diabetes · NA · completed
- NCT07045506 — Estimating Umbilical Venous Catheter Insertion Depth in Newborns Using Weight or Body Measurements: A Multicenter Random · NA · completed
- NCT04351425 — Early Weaning of Preterm Newborn From Incubator to Cot at 1400 Grams · NA · unknown
- NCT04229199 — Effectiveness of Preoperative Tour in Simulation Operating Theater in Reducing Preoperative Anxiety in Children · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04386525 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Fahad Medical City
- Last refreshed: 14 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04386525.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing